Code | 1631C | ||||||||||
MA number | 31/0476/16-S | ||||||||||
Product Form: | tbl 180x10 mg/40 mg (obal HDPE) | ||||||||||
MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
Type of procedure: | Mutual recognition procedure | ||||||||||
MAH, country: | Teva B.V., Netherland | ||||||||||
Therapeutic Class: | 31 - HYPOLIPIDAEMICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 24 | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 10(1) generic application |
MA issued: | 14.11.2016 |
Pediatric posology: | Yes |
Pediatric warnings: | Yes |
PIL: |
|
SPC: |
|
Safety feature | Yes |
Data update: | 23.09.2019 |